Back to Journals » Vascular Health and Risk Management » Volume 15

High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus

Authors Artha IMJR, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, Yuwono J, Bhargah V, Prabawa IPY, Manuaba IBAP, Rina IK

Received 24 March 2019

Accepted for publication 3 May 2019

Published 5 June 2019 Volume 2019:15 Pages 149—157

DOI https://doi.org/10.2147/VHRM.S209830

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr Pietro Scicchitano


Video abstract presented by Agha Bhargah.

Views: 42

I Made Junior Rina Artha,1 Agha Bhargah,1,2 Nyoman Khrisna Dharmawan,2 Utami Wijayaswari Pande,2 Komang Agus Triyana,2 Pande Agung Mahariski,2 Jessica Yuwono,2 Varennia Bhargah,2 I Putu Yuda Prabawa,3 Ida Bagus Amertha Putra Manuaba,4,5 I Ketut Rina6

1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia; 2Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia; 3Clinical Pathology Department, Faculty of Medicine, Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia; 4International Ph.D Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 5Medical and Health Education Unit, Faculty of Medicine, Udayana University, Denpaser, Bali, Indonesia; 6Cardiology Department, Puri Raharja General Hospital, Denpasar, Bali, Indonesia

Introduction: Diabetes is often accompanied by undiagnosed dyslipidemia. The aim of the study is to investigate the clinical relevance of lipid profiles and lipid ratios as predictive biochemical models for glycemic control in patients with type 2 diabetes mellitus (T2DM).
Methods: This is a retrospective study recruiting 140 patients with T2DM during a one-year period, 2018–2019, at the Diabetic Center Sanglah General Hospital and Internal Medicine Polyclinic Puri Raharja General Hospital. Demographic characteristics, glycosylated hemoglobin (HBA1c) , and lipid profile were recorded and analyzed using SPSS version 25.0 for Windows. The sample is then classified into good (HBA1c≤7) and poor (HBA1c>7) glycemic control. Risk analysis model, receiver operator characteristics (ROC) analysis, and correlation test were used to evaluate the association of HBA1c level with lipid profile and lipid ratio parameters.
Result: Lipid profile findings such as total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) , triglycerides (TG), and lipid ratio parameter (LDL-C to high-density lipoprotein cholesterol (HDL-C) ratio) were higher in patients in the poor glycemic control group (p<0.05) and HDL-C was significantly lower in patients with poor glycemic control (p=0.001). There is a significant positive correlation between LDL, total cholesterol, LDL-C, TG, and TC to HDL-C ratio, triglycerides, and TC/HDL-C ratio with HBA1c level. Meanwhile, a negative correlation was observed on HDL-C with the HBA1c level. Only TC/HDL-C ratio and LDL-C/HDL-C ratio parameters may be used as predictive models (AUC>0.7), with cutoff point, sensitivity, and specificity of 4.68 (77%; 52%) and 3.06 (98%; 56%) respectively. A risk analysis model shows that the LDL-C/HDL-C ratio parameter is the most influential risk factor in the occurrence of poor glycemic control (adjusted OR =38.76; 95% CI: 27.32–56.64; p<0.001).
Conclusion: Lipid profiles (LDL-C) and lipid ratios (LDL-C/HDL-C and TC/HDL-C ratio) show potential markers that can be used in predicting glycemic control in patients with T2DM.

Keywords: dyslipidemia, glycemic, diabetes, risk

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]